Reproducibility and replicability of high-frequency, in-home digital biomarkers in reducing sample sizes for clinical trials.
Chao-Yi WuZachary BeattieNora MattekNicole SharmaJeffrey KayeHiroko H DodgePublished in: Alzheimer's & dementia (New York, N. Y.) (2021)
Reproducibility and replicability of digital biomarker analyses are feasible and encouraged to establish the reliability of findings.